 |
 |
 |
|
Ariadne's thread, which has guided ICTA's entrepreneurial evolution over these last 30 years, is without doubt the quality of the exchanges built with our clients. We have indeed kept on questioning and analysing their needs, their wishes and their expectations. Some of our collaborations turned into genuine partnerships especially when ICTA first applied systemic analysis to Clinical R&D and initiated the use of new biomathematic methodologies among which the Bayesian approaches. We can only thank our customers for their support, their confidence, their remarks and their advice. ICTA's development was driven by a twofold strategy: On the one hand, to develop the package of services making up the full-service necessary to achieve a successful clinical development ; On the other hand, to open up to the academic environment so as to provide the expertise-based and innovative services that will meet our clients' quality requisites and will guarantee them a return on investment. |
||
|
Systemic modelling |
Extensive use of systemic modelling, including functional analysis (IVMS*), for writing ICTA's set of procedures, the quality and effectiveness of which are witnessed by all the audits conducted by our clients. |
|
|
Value analysis |
Use of Value Analysis to analyse the objectives and to assess solutions, which means offering a top of the range service for optimized costs. |
|
|
Clinical studies and adaptive management |
Creation of the innovative structure of Themis Institute which, well before the recommendations of the "Clinical Path Opportunity Report" by the FDA, had tested the use of Bayesian adaptive methodologies in early phases of development. Hence the European leadership ICTA provides in clinical R&D of phases I and II. |
|
|
Collaborative platform and e-CRF |
Setting up of an IT department which develops and provides bespoke and effective tools, just to name its e-CRFs and its I-SIT collaborative platform (ICTA Secure Information Technology). |
|
|
Aid to decision making |
Thus, the provision of all KDD* methodologies (decision trees, multi-dimensional analyses, genetic algorithms, Bayesian networks, neural analyses) to promote and apply innovative analysis methods including artificial intelligence to provide a better understanding of the relations between variables. |
|
|
Each of the components of ICTA's clinical R&D service, i.e. medical and methodological design, regulatory affairs, project management, monitoring, IT developments, biostatistics and biomathematics, and pharmacovigilance have developed as stand-alone activities while building a coherent full-service with well-balanced departments centralized at ICTA's headquarters. * IVMS: ICTA Value Management System * KDD : Knowledge Discovery and Data mining |
||